# A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

> **NCT01481701** · PHASE2 · COMPLETED · sponsor: **Jules Bordet Institute** · enrollment: 90 (estimated)

## Conditions studied

- Ovarian Carcinoma
- Relapse

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT01481701
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2014-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481701, "A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01481701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*